Liminatus Pharma, Inc. (LIMN) › Capital ExpendituresLiminatus Pharma, Inc. (LIMN) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.Fiscal YearCapital ExpendituresChange YoY2025$13.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share